MLB Announces 80-Game Suspension For Johan Rojas Major League Baseball announced today that Phillies outfielder Johan Rojas has received an 80-game suspension after testing positive for Boldenone, a performance-enhancing substance, in violation of the league’s Joint Drug Prevention and Treatment Program. The suspension was confirmed after Rojas’s appeal process concluded, and he will begin serving the penalty during the 2026 season. Rojas, 25, has been a key player for the Phillies as their center fielder over the past three seasons, known for his defensive skills and base-stealing ability. However, his offensive production has been inconsistent, with a .237/.279/.312 batting line since 2024, translating to a 64 wRC+—36% below league average. His struggles at the plate have prompted the Phillies to seek alternatives, leading to the acquisition of Harrison Bader in 2025. Bader, now a free agent, is expected to take over the center field role, with prospect Justin Crawford serving as a potential backup. Rojas’s suspension removes him from contention for a starting role in 2026. Without him, the Phillies face a challenge in center field depth. Left fielder Brandon Marsh has experience in the position but is defensively limited, while Pedro León, a 40-man roster player with only seven major league games under his belt, and utility man Dylan Moore, who has limited center field experience, are potential options. The team may need to explore waivers or free agency in the coming weeks to address the gap. The suspension also raises questions about the Phillies’ roster flexibility. With Rojas ineligible for the postseason, the team may look to add depth in center field as Opening Day approaches.#jurickson_profar #mlb #philadelphia_phillies #johan_rojas #boldenone
Phillies have a PED problem after yet another suspension CLEARWATER, Fla. — The Philadelphia Phillies face mounting scrutiny over a recurring issue involving performance-enhancing drugs (PEDs), as the team has been hit with its eighth suspension this season, tying them with Seattle for the most in Major League Baseball history. Johan Rojas became the latest Phillie to be suspended after testing positive for boldenone, a banned substance, prompting an arbitrator to uphold an 80-game ban. This marks the third Phillies player linked to the team to receive a PED suspension within a single calendar year, a record that has never been matched by any other franchise. The Phillies’ struggles with PED violations date back to 2009, when J.C. Romero was suspended. Since then, the team has seen suspensions involving players like Freddy Galvis, Carlos Ruiz, Antonio Bastardo, Daniel Stumpf, Alec Asher, and J.C. Romero. Adding to the tally, Max Kepler, a free agent who played for the Phillies last season, was suspended for 80 games in January after testing positive for a PED. Including Kepler, the Phillies now have nine suspensions tied to the team in 2026, a number that underscores the league’s growing concern over the organization’s history. Manager Rob Thomson, who took over as manager in 2022, has dismissed the suspensions as isolated incidents, stating, “They are three totally different situations. So no, I do not think it’s an issue.” However, the team’s front office has remained silent on the matter, citing an MLB rule that prohibits commentaries on suspensions. The Phillies issued a statement expressing support for MLB’s Joint Prevention and Treatment Program but stopped short of addressing the broader implications of the suspensions.#mlb #philadelphia_phillies #johan_rojas #jc_romero #rob_thomson
Phillies' Johan Rojas suspended 80 games for failed drug test The Philadelphia Phillies' Johan Rojas has been suspended for 80 games after failing a drug test. The suspension was announced on March 16, 2026, at 06:24 PM ET. Rojas, a reliever for the Phillies, tested positive for a prohibited substance, prompting the league to impose the penalty. The decision follows standard procedures for handling such violations, which typically involve a review of the testing process and confirmation of the results. The suspension will begin with the 2026 season, impacting Rojas' availability for the majority of the campaign. The Phillies have not yet commented on the specifics of the case or the potential implications for the team's roster. This marks the latest in a series of disciplinary actions taken by Major League Baseball to address performance-enhancing drug use.#2026_season #phillies #johan_rojas #major_league_baseball #drug_test
